Madrigal Pharmaceuticals
MDGL
#1797
Rank
C$16.17 B
Marketcap
C$701.39
Share price
-0.51%
Change (1 day)
73.45%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -C$0.4 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are C$1.13 Billion. In 2025 the company made an earning of -C$0.37 Billion, an increase over its 2024 earnings that were of -C$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.4 Billion6.71%
2025 -C$0.37 Billion-41.05%
2024 -C$0.63 Billion25.02%
2023 -C$0.5 Billion23.86%
2022 -C$0.41 Billion20.24%
2021 -C$0.34 Billion17.25%
2020 -C$0.29 Billion117.61%
2019 -C$0.14 Billion189.45%
2018 -C$45.2 Million3.85%
2017 -C$43.52 Million25.71%
2016 -C$34.62 Million-50.81%
2015 -C$70.38 Million-39.14%
2014 -C$0.12 Billion-4.12%
2013 -C$0.13 Billion
2011 -C$62.58 Million23.13%
2010 -C$50.83 Million-145.81%
2009 C$0.11 B-185.95%
2008 -C$0.13 Billion41.52%
2007 -C$91.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion-43.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.01 Million-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA